Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
National Journal of Andrology ; (12): 353-360, 2017.
Article in Chinese | WPRIM | ID: wpr-812760

ABSTRACT

Objective@#To explore the effects of Kudzu Root plus Cinnamon Granules (KR+C) on prostatic hyperplasia (PH) in mice.@*METHODS@#Sixty 4-week-old Kunming male mice were randomly divided into six groups: blank control, PH model, high-, medium- and low-dose KR+C, and finasteride control. All the mice except those in the blank control group were subcutaneously injected with testosterone propionate (5 mg / [kg·d]) at 7 days after surgical castration. The animals of different groups were treated intragastrically with different doses of KR+C, finasteride, and normal saline respectively for 3 weeks and then sacrificed for weighing of the prostate, calculation of the prostatic index, observation of the morphological changes in the prostate after HE staining, determination of the expressions of FGF2, Ki67 and TGF-β1 by immunohistochemistry, detection of 5α-reductase activity by ELISA, and measurement of the apoptosis index of the prostatic cells by TUNEL.@*RESULTS@#Compared with the model controls, the mice of the other groups showed significantly reduced prostatic volume (P 0.05).@*CONCLUSIONS@#KR+C can reduce the prostatic volume of PH mice by decreasing the activity of 5α- reductase, inhibiting the expressions of FGF2, Ki67 and TGF-β1, and promoting the apoptosis of prostatic cells.


Subject(s)
Animals , Male , Mice , Apoptosis , Cholestenone 5 alpha-Reductase , Metabolism , Cinnamomum zeylanicum , Chemistry , Fibroblast Growth Factor 2 , Metabolism , Finasteride , Therapeutic Uses , In Situ Nick-End Labeling , Ki-67 Antigen , Metabolism , Organ Size , Phytotherapy , Methods , Plant Roots , Chemistry , Prostate , Pathology , Prostatic Hyperplasia , Drug Therapy , Metabolism , Pathology , Pueraria , Chemistry , Random Allocation , Testosterone Propionate , Transforming Growth Factor beta1 , Metabolism , Urological Agents , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL